Velocity Financial 株価情報 (NYSE: VEL)

最新ニュース Velocity Financial (NYSE:VEL) 株価情報

Velocity Financial

Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

Velocity Financial Inc

Velar - United States Dollar

Velo - United States Dollar

Canadian Overseas Petroleum Ltd

CANADIAN OVRSEA PETE LTD by Canadian Overseas Petroleum Ltd.

Northland Capital Markets analyst Jeff Grampp initiates coverage on Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) with a Market Perform rating and announces Price Target of $16.

News

Price Target

Initiation

Analyst Ratings

Northland Capital Markets Initiates Coverage On Flotek Industries with Market Perform Rating, Announces Price Target of $16

Trading Ideas

HUSA

Houston American Energy Shares Resume Trade

RBC Capital analyst Leonid Timashev maintains Nuvation Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NYSE">NUVB</a>) with a Outperform and lowers the price target from $10 to $6.

NUVB

RBC Capital Maintains Outperform on Nuvation Bio, Lowers Price Target to $6

Noble Capital Markets analyst Joe Gomes maintains Kratos Defense &amp; Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) with a Outperform and raises the price target from $38 to $44.

KTOS

Noble Capital Markets Maintains Outperform on Kratos Defense & Security, Raises Price Target to $44

<ul>
<li>The U.S. Federal Aviation Administration (FAA) and the Department of Transportation (DOT) held a press conference today to announce a five-country alliance to streamline the certification and safe deployment of eVTOL aircraft.</li>
<li>Led by the United States, this alliance also includes the United Kingdom, Australia, Canada and New Zealand.</li>
<li>Archer and industry peers were invited to join the DOT and FAA at the Paris Air Show today to make this announcement.</li>
</ul>
Today Archer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) joined leaders from the FAA and DOT, including Transportation Secretary Sean P. Duffy and acting FAA Administrator, Chris Rocheleau, to announce the formation of this five-country alliance to streamline the certification and deployment of eVTOL aircraft globally. This alliance includes the United States, United Kingdom, Australia, Canada and New Zealand.

ACHR

Archer Joins Transportation Secretary Sean Duffy And Acting FAA Administrator, Chris Rocheleau, To Announce Five-Country Alliance To Streamline Certification And Deployment Of eVTOL Aircraft

WIIM

RCAT

Red Cat Holdings shares are trading lower after the company announced a $46.75 million registered direct offering of 6.45 million shares of common stock.

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Sector Perform and lowers the price target from $423 to $420.

VRTX

RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Lowers Price Target to $420

Rumors

IPOs

MENS

Jyong Biotech IPO Quoting $12.05/Share On 65K Shares; IPO Priced At $7.50/Share on ~2.67M Shares

Macro Economic Events

Market Summary

Economics

General

FSLR

Benzinga Market Summary: S&P Pulls Back And Oil Surges After President Trump Denies Working On Israel-Iran Ceasefire, Solar Stocks Fall On Trump Tax Bill

Morgan Stanley analyst James Faucette maintains Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) with a Equal-Weight and raises the price target from $305 to $310.

Morgan Stanley Maintains Equal-Weight on Automatic Data Processing, Raises Price Target to $310

Morgan Stanley analyst Manan Gosalia maintains Commerce Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBSH#NASDAQ">CBSH</a>) with a Equal-Weight and raises the price target from $58 to $61.

CBSH

Morgan Stanley Maintains Equal-Weight on Commerce Bancshares, Raises Price Target to $61

<a href="https://www.axios.com/2025/06/17/trump-situation-room-meeting-iran-israel-war">https://www.axios.com/2025/06/17/trump-situation-room-meeting-iran-israel-war</a>

Politics

iShares MSCI Israel Capped Investable Market Index Fund

'Trump to hold Situation Room meeting on Iran'- Axios

Houston American Energy Shares Halted On Circuit Breaker To The Upside, Stock Now Up 70.4%

U.S. stocks were lower, with the Dow Jones index falling over 50 points on Tuesday.
Shares of Jabil Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/JBL/earnings">third-quarter EPS and sales.</a>
The company reported quarterly adjusted earnings per share of $2.55, beating the analyst consensus estimate of $2.31. Quarterly sales of $7.83 billion outpaced the analyst consensus estimate of $7.06 billion.
Jabil shares climbed 12% to $202.75 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Verve Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) shares jumped 75.4% to $11.00 after the company announced it will be acquired by Eli Lilly.</li>
<li>Digital Turbine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) surged 44% to $6.92 after reporting better-than-expected fourth-quarter EPS and sales.</li>
<li>Regencell Bioscience Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) climbed 25% to $75.05.</li>
<li>Purecycle Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) surged 22.8% to $14.70 after the company announced it raised $300 million to support its global expansion toward 1B pounds. Also, the company announced a partnership with IRPC to build 130-million-pound polypropylene recycling facility in Thailand.</li>
<li>LiveWire Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) climbed 21.5% to $6.25.</li>
<li>Focus Impact BH3 Acquisition Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFX#NASDAQ">SAFX</a>) gained 19.2% to $2.64.</li>
<li>PACS Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) gained 17.1% to $11.89.</li>
<li>Fluence Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) rose 13.3% to $5.68.</li>
<li>John Wiley &amp; Sons Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) gained 12.8% to $41.79 after the company reported better-than-expected quarterly financial results and issued FY26 adjusted EPS guidance above estimates.</li>
<li>Intellia Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) gained 11.7% to $10.01.</li>
<li>Crispr Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) rose 7.6% to $44.72.</li>
<li>Oscar Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) gained 7.4% to $16.06.</li>
<li>Remitly Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) gained 7% to $20.90.</li>
<li>Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) rose 5.8% to $133.86.</li>
<li>Bath &amp; Body Works Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) gained 4.5% to $26.99.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45970767/top-3-health-care-stocks-that-are-ticking-portfolio-bombs">Top 3 Health Care Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

APPS

BBWI

CRSP

FLNC

LVWR

NTLA

OSCR

PACS

RDDT

RELY

SAFX

VERV

Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday

Morgan Stanley analyst Erik Woodring maintains Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) with a Overweight and raises the price target from $70 to $78.

Morgan Stanley Maintains Overweight on Western Digital, Raises Price Target to $78

Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) with a Overweight and raises the price target from $52 to $56.

CGON

Morgan Stanley Maintains Overweight on CG Oncology, Raises Price Target to $56

Disclosed in the latest SEC filing, a significant insider purchase on June 16, involves JACK CORRIGAN, Director at American Homes 4 Rent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMH#NYSE">AMH</a>).
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001562401/000156240125000054//Archives/edgar/data/1562401/000156240125000054/0001562401-25-000054-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that CORRIGAN purchased 4,000 shares of American Homes 4 Rent. The total transaction amounted to $91,700. 
Monitoring the market, American Homes 4 Rent's shares up by 0.5% at $36.24 during Tuesday's morning.
<h3>Discovering American Homes 4 Rent: A Closer Look</h3>
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
<h3>American Homes 4 Rent's Economic Impact: An Analysis</h3>
Revenue Growth: Over the 3 months period, American Homes 4 Rent showcased positive performance, achieving a revenue growth rate of 8.43% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 56.08%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): American Homes 4 Rent's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 0.3.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.69, American Homes 4 Rent adopts a prudent financial strategy, indicating a balanced approach to debt management.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 33.39 is lower than the industry average, implying a discounted valuation for American Homes 4 Rent's stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 7.54 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 16.17, American Homes 4 Rent presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001562401">Check Out The Full List Of American Homes 4 Rent's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Noteworthy Insider Activity: JACK CORRIGAN Invests $91K In American Homes 4 Rent Stock

Revealing a significant insider sell on June 16, Dallas Tanner, Chief Executive Officer at Invitation Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>), as per the latest SEC filing.
What Happened: After conducting a thorough analysis, Tanner sold 148,749 shares of Invitation Homes. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001687229/000095017025086815//Archives/edgar/data/1687229/000095017025086815/0000950170-25-086815-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total transaction value is $4,970,001.
The latest update on Tuesday morning shows Invitation Homes shares down by 0.69%, trading at $33.15.
<h3>All You Need to Know About Invitation Homes</h3>
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.
<h3>Invitation Homes's Economic Impact: An Analysis</h3>
Positive Revenue Trend: Examining Invitation Homes's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.4% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Real Estate sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 59.35%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Invitation Homes's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 0.27.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.83.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Invitation Homes's P/E ratio of 42.79 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 7.74 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 18.24, Invitation Homes presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001687229">Check Out The Full List Of Invitation Homes's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INVH

Chief Executive Officer Of Invitation Homes Sold $4.97M In Stock

Revealing a significant insider sell on June 16, Solus Alternative Asset Management LP, 10% Owner at Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>), as per the latest SEC filing.
What Happened: LP's recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001525221/000090266425002736//Archives/edgar/data/1525221/000090266425002736/0000902664-25-002736-index.htm">U.S. Securities and Exchange Commission</a> on Monday unveiled the sale of 45,857 shares of Bristow Group. The total transaction value is $1,535,640.
During Tuesday's morning session, Bristow Group shares down by 0.0%, currently priced at $34.11.
<h3>About Bristow Group</h3>
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.
<h3>Unraveling the Financial Story of Bristow Group</h3>
Revenue Growth: Bristow Group's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 3.99%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 64.89%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.95, Bristow Group showcases strong earnings per share.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.02, caution is advised due to increased financial risk.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 8.75 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.71 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Bristow Group's EV/EBITDA ratio, lower than industry averages at 6.95, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001525221">Check Out The Full List Of Bristow Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VTOL

Insider Selling: Solus Alternative Asset Management LP Unloads $1.54M Of Bristow Group Stock

Yann Echelard, Director at TG Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>), disclosed an insider sell on June 16, according to a recent SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001001316/000143774925020546//Archives/edgar/data/1001316/000143774925020546/0001437749-25-020546-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that Echelard sold 10,000 shares of TG Therapeutics. The total transaction amounted to $369,400. 
In the Tuesday's morning session, TG Therapeutics's shares are currently trading at $35.05, experiencing a down of 1.63%.
<h3>Unveiling the Story Behind TG Therapeutics</h3>
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.
<h3>Financial Milestones: TG Therapeutics's Journey</h3>
Positive Revenue Trend: Examining TG Therapeutics's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 90.4% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 87.14%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): TG Therapeutics's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.03.
</li>
</ul>
Debt Management: TG Therapeutics's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: TG Therapeutics's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 142.52.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 15.17 is above industry norms, reflecting an elevated valuation for TG Therapeutics's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): TG Therapeutics's EV/EBITDA ratio of 78.48 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001001316">Check Out The Full List Of TG Therapeutics's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TGTX

Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock

Press Releases

Velocity Financial, Inc. Announces Date of Second Quarter 2024 Financial Results Webcast and Conference Call

Velocity Financial, Inc. Reports Second Quarter 2024 Results

Velocity Financial, Inc. Announces Date of Third Quarter 2024 Financial Results Webcast and Conference Call

Velocity Financial, Inc. Reports Third Quarter 2024 Results

Velocity Financial, Inc. Announces Date of Fourth Quarter and Full-Year 2024 Financial Results Webcast and Conference Call

Velocity Financial, Inc. Reports Fourth Quarter and Full Year 2024 Results

Velocity Financial, Inc. Announces Date of First Quarter 2025 Financial Results Webcast and Conference Call

Velocity Financial, Inc. Reports First Quarter 2025 Results

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

Mr. Cooper Gr

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Comments

Velocity Financial

ニュース

最新ニュース Velocity Financial (NYSE:VEL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル